Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Change in Inventory (2012 - 2026)

Kamada's (KMDA) quarterly Change in Inventory came in at -$1.4 million in Q2 2026, up 61.35% on a YoY basis from -$891205.5 in Q2 2025, and down 191.09% quarter-over-quarter from -$494000.0 in Q1 2026.

Analysis

Kamada (KMDA) Change in Inventory (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Change in Inventory for 15 consecutive years, with -$1.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Inventory rose 61.35% year-over-year to -$1.4 million; the trailing twelve-month figure through Jun 2026 stood at -$4.8 million (down 42.48% YoY), and the FY2025 full-year result was -$6.1 million, down 163.4% from the prior year.
  • Change in Inventory fell to -$1.4 million in Q2 2026 per KMDA's latest filing, from -$494000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $7.2 million in Q3 2024 and bottomed at -$14.7 million in Q4 2023.
  • Historically, Change in Inventory has averaged -$1.1 million across 5 years, with a median of -$120500.0 in 2022.
  • The sharpest annual moves came in 2023 and 2024: Change in Inventory slumped 512.1% in 2023, then surged 1268.88% in 2024.
  • Over 5 years, Change in Inventory stood at $4.2 million in 2022, then slumped by 445.89% to -$14.7 million in 2023, then soared by 50.55% to -$7.3 million in 2024, then surged by 106.46% to $469000.0 in 2025, then sank by 406.61% to -$1.4 million in 2026.
  • According to Business Quant data, Change in Inventory over the past three periods registered -$1.4 million, -$494000.0, and $469000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Inventory (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 31.00 Mn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 145.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 27.70 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 28.20 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 132.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -280,000.00
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -75.70 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn -1.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.44 Mn
Mar 31, 2026 -494,000.00
Dec 31, 2025 469,000.00
Sep 30, 2025 -3.33 Mn
Jun 30, 2025 -3.72 Mn
Mar 31, 2025 461,000.00
Dec 31, 2024 -7.26 Mn
Sep 30, 2024 7.16 Mn
Jun 30, 2024 5.63 Mn
Mar 31, 2024 4.13 Mn
Dec 31, 2023 -14.68 Mn
Sep 30, 2023 6.44 Mn
Jun 30, 2023 -482,000.00
Mar 31, 2023 -10.97 Mn
Dec 31, 2022 4.25 Mn
Sep 30, 2022 -8.51 Mn
Jun 30, 2022 241,000.00
Mar 31, 2022 2.66 Mn
Dec 31, 2021 3.59 Mn
Sep 30, 2021 -3.56 Mn